TREATMENT OF METASTATIC COLORECTAL-CARCINOMA WITH CISPLATIN AND 5-FU

被引:0
|
作者
SHEPARD, KV
FAINTUCH, J
BITRAN, JD
SWEET, DL
ROBIN, E
LEVIN, B
机构
[1] UNIV CHICAGO HOSP & CLIN,DEPT MED,GASTROINTESTINAL ONCOL UNIT,5841 S MARYLAND AVE,BOX 400,CHICAGO,IL 60637
[2] MICHAEL REESE HOSP & MED CTR,DEPT MED,CHICAGO,IL 60616
[3] HINDALE HOSP,DEPT MED,CHICAGO,IL
[4] INGALLS HOSP,DEPT MED,CHICAGO,IL
来源
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 01期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:123 / 124
页数:2
相关论文
共 50 条
  • [31] FLUORDEOXYURIDINE AND METASTATIC COLORECTAL-CARCINOMA
    WOLFF, SN
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) : 491 - 492
  • [32] Oxaliplatin with 5-FU or as a single agent in advanced/metastatic colorectal cancer
    Mitchell, EP
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 30 - 32
  • [33] AMONAFIDE IN METASTATIC COLORECTAL-CARCINOMA
    SCHEITHAUER, W
    KORNEK, G
    HAIDER, K
    DEPISCH, D
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (08) : 923 - 924
  • [34] Hospitalization for 5-FU toxicity in metastatic colorectal cancer: Incidence and cost
    Oster, G
    ONCOLOGY-NEW YORK, 1999, 13 (07): : 41 - 43
  • [35] PHASE-I EVALUATION AND PHARMACOKINETIC STUDY OF WEEKLY IV THYMIDINE AND 5-FU IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    LYNCH, G
    KEMENY, N
    CHUN, H
    MARTIN, D
    YOUNG, C
    CANCER TREATMENT REPORTS, 1985, 69 (02): : 179 - 184
  • [36] Phase I study of 5-FU and arsenic trioxide (ATO) in patients with refractory metastatic colorectal carcinoma
    Ardalan, B.
    Subbarayan, P. R.
    Ramos, Y.
    Gonzalez, M.
    Mezentsev, D.
    Reis, I. M.
    Duncan, R.
    Ganjei-Azar, P.
    Lee, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] RANDOMIZED STUDY OF 2 DIFFERENT SCHEDULES OF METHYL CCNU, 5-FU AND VINCRISTINE FOR METASTATIC COLORECTAL CARCINOMA
    KEMENY, N
    YAGODA, A
    BRAUN, D
    GOLBEY, R
    CANCER, 1979, 43 (01) : 78 - 82
  • [38] CISPLATIN AND ETOPOSIDE IN ADVANCED COLORECTAL-CARCINOMA
    PASSALACQUA, R
    BISAGNI, G
    COCCONI, G
    BONI, C
    DIBLASIO, B
    CECI, G
    ANNALS OF ONCOLOGY, 1991, 2 (09) : 687 - 688
  • [39] COMPARISON OF 5-FU AND DOXORUBICIN IN THE TREATMENT OF CARCINOMA OF THE BLADDER
    KNIGHT, EW
    PAGAND, M
    HAHN, RG
    HORTON, J
    CANCER TREATMENT REPORTS, 1983, 67 (05): : 514 - 515
  • [40] PHASE-II TRIAL OF CONTINUOUS-INFUSION IPROPLATIN (CHIP) AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLORECTAL-CARCINOMA
    PETRELLI, NJ
    CREAVEN, PJ
    HERRERA, L
    MITTELMAN, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (01) : 61 - 62